Verismo Therapeutics
Nora Yucel is a Translational Scientist at Verismo Therapeutics since January 2023, bringing a strong background in research. Prior to this role, Nora served as a Postdoctoral Researcher at the University of Pennsylvania from September 2017 to January 2023 and as a Graduate Student at Stanford University from April 2011 to August 2017. Nora began their research career as an Undergraduate Researcher at the University of Chicago between April 2007 and June 2010. Educationally, Nora holds a Bachelor of Science in Biochemistry from the University of Chicago (2006-2010) and completed advanced studies at Stanford University from 2010 to 2016.
This person is not in any offices
Verismo Therapeutics
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.